Navigation Links
PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma

PISCATAWAY, N.J., Nov. 19, 2013 /PRNewswire/ -- PBL Assay Science announces the expansion of its assay services portfolio to include 38 different ultra-sensitive biomolecule assays using the Singulex® Erenna® Immunoassay technology.  Based on an innovative single-molecule counting (SMC) technology, these services are designed to provide sub-picogram per ml sensitivity for analytes in human serum or plasma.  The background reduction methodology of this detection service extends the linear dynamic range to over 4 logs, allowing a wide concentration range of biomarker measurement with minimal dilution in many disease states.

"We are proud to offer ultra-sensitive cytokine detection services to researchers around the world," said Dr. Thomas Lavoie, Director of Product Research & Development and Assay Services at PBL.  "The ability to measure basal levels of cytokines and other biomarkers in the femtogram per ml range will enable far deeper analysis of changes in these biomarkers, enhancing our understanding of various diseases and disease therapies, and allowing for earlier project milestone decisions, saving our clients time and money."

The addition of ultra-sensitive cytokine detection services signifies PBL's commitment in providing the best service solutions to meet scientists' assay needs.  It complements the company's single-analyte ELISA, cytokine multiplex ELISA, and cell-based activity assay services that are currently offered in their sample testing and screening catalog.

Ultra-sensitive assay services offered by PBL include detection for cytokines such as human IL-17A, IL-17F, IL-17 A/F heterodimer, IL-6, IL-1alpha, IL-1beta, IL-10, IL-15, TNF-alpha, GLP-1, and biomarkers such as cardiac troponin-I.  For additional information about this technology, view our poster presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference.  To learn more about these services, contact Stephen Parent, the company's Director of Business Development, at or 1-732-777-9123 ext. 117.

About PBL Assay Science

PBL Assay Science is a major provider of products, services, information, and know-how related to interferons, cytokines, antibodies, ELISAs, and assay solutions.  The company employs state-of-the-art technology in conducting assay services and manufacturing world-class products for scientists around the globe each day. Learn more at


Stephen A. Parent

(732) 777-9123 x 117

SOURCE PBL Assay Science
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IntelligentMDx Receives FDA Clearance for IMDx C. difficile for Abbott m2000 Assay, Completes Move of Corporate Headquarters to Waltham
2. FDA Approves Aptima HPV 16 18/45 Genotype Assay for Use on Hologics Panther System
3. Quantum Materials Engineers Tetrapod Quantum Dots to Improve Diagnostic Accuracy of Biomedical Assays and Devices
4. Sharp Edge Labs and SpectraGenetics Sign Agreement to Provide Better Assays for Studying G-Protein Coupled Receptors
5. Beckman Coulter Receives FDA Clearance of AccuTnI+3 Troponin I Assay on UniCel DxI Immunoassay Systems
6. IntelligentMDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay
8. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
9. Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays
10. Markteinführung neuer Assays für Magen-Darm Infektionen in Europa
11. Profil Institute and Mercodia Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
(Date:11/25/2015)... Asia -based venture ... and the New Investors will make a direct equity ... private placement. The financing will help IOPtima to continue ... in the treatment of glaucoma, as well as to ... system with the U.S. Food and Drug Administration, commencing ...
(Date:11/25/2015)... , November 25, 2015 Developmental, commercial, ... in boosting the profitability of pharmaceutical products, says ... and regulatory/legal strategies all play a key ... says GBI Research . --> ... a key role in boosting the profitability of pharmaceutical products, ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is ... 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What an ... every day excited to rebuild lives and it’s an honor to have served all ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film ... trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 ... with any font, giving users limitless opportunities to stylize and create designs quickly ...
(Date:11/26/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact ... and reliability. , The new Q-Suite 6 platform is based on the latest Java ... into a specific piece of software for many key components of the suite. Much ...
(Date:11/25/2015)... Indianapolis, IN (PRWEB) , ... November 25, 2015 ... ... clean water accessible for all, Water For Empowerment ™ attracts volunteers together ... on clean water by empowering women as key stakeholders in the process. The ...
Breaking Medicine News(10 mins):